Structure

Physi-Chem Properties

Molecular Weight:  684.26
Volume:  644.071
LogP:  -0.202
LogD:  -0.066
LogS:  -2.686
# Rotatable Bonds:  12
TPSA:  246.68
# H-Bond Aceptor:  16
# H-Bond Donor:  9
# Rings:  5
# Heavy Atoms:  16

MedChem Properties

QED Drug-Likeness Score:  0.113
Synthetic Accessibility Score:  4.985
Fsp3:  0.625
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.541
MDCK Permeability:  8.431488822679967e-05
Pgp-inhibitor:  0.0
Pgp-substrate:  0.997
Human Intestinal Absorption (HIA):  0.897
20% Bioavailability (F20%):  0.025
30% Bioavailability (F30%):  0.996

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.134
Plasma Protein Binding (PPB):  48.34331512451172%
Volume Distribution (VD):  0.468
Pgp-substrate:  18.40015983581543%

ADMET: Metabolism

CYP1A2-inhibitor:  0.016
CYP1A2-substrate:  0.049
CYP2C19-inhibitor:  0.006
CYP2C19-substrate:  0.32
CYP2C9-inhibitor:  0.0
CYP2C9-substrate:  0.125
CYP2D6-inhibitor:  0.004
CYP2D6-substrate:  0.204
CYP3A4-inhibitor:  0.015
CYP3A4-substrate:  0.045

ADMET: Excretion

Clearance (CL):  1.38
Half-life (T1/2):  0.627

ADMET: Toxicity

hERG Blockers:  0.404
Human Hepatotoxicity (H-HT):  0.133
Drug-inuced Liver Injury (DILI):  0.207
AMES Toxicity:  0.126
Rat Oral Acute Toxicity:  0.014
Maximum Recommended Daily Dose:  0.003
Skin Sensitization:  0.611
Carcinogencity:  0.286
Eye Corrosion:  0.003
Eye Irritation:  0.01
Respiratory Toxicity:  0.009

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC471063

Natural Product ID:  NPC471063
Common Name*:   4,4'-O-Lariciresinol-Bis-Glucoside
IUPAC Name:   (2S,3R,4R,5S,6R)-2-(hydroxymethyl)-6-[4-[[(3S,4S,5R)-4-(hydroxymethyl)-5-[3-methoxy-4-[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]oxolan-3-yl]methyl]-2-methoxyphenoxy]oxane-3,4,5-triol
Synonyms:  
Standard InCHIKey:  PBLWZMSRSJTRHJ-SXCKUSEKSA-N
Standard InCHI:  InChI=1S/C32H44O16/c1-42-20-8-14(3-5-18(20)45-31-28(40)26(38)24(36)22(11-34)47-31)7-16-13-44-30(17(16)10-33)15-4-6-19(21(9-15)43-2)46-32-29(41)27(39)25(37)23(12-35)48-32/h3-6,8-9,16-17,22-41H,7,10-13H2,1-2H3/t16-,17-,22+,23+,24+,25+,26-,27-,28+,29+,30+,31+,32+/m1/s1
SMILES:  OC[C@@H]1O[C@H](Oc2ccc(cc2OC)C[C@@H]2CO[C@H]([C@@H]2CO)c2ccc(c(c2)OC)O[C@H]2O[C@@H](CO)[C@@H]([C@H]([C@@H]2O)O)O)[C@H]([C@@H]([C@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL234142
PubChem CID:   44429874
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0001392] Lignans, neolignans and related compounds
      • [CHEMONTID:0001511] Lignan glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO6536 Marrubium velutinum Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[17287127]
NPO6536 Marrubium velutinum Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO6536 Marrubium velutinum Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT43 Individual Protein Tyrosinase Agaricus bisporus Inhibition = 11.06 % PMID[469884]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC471063 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9855 High Similarity NPC205796
0.9855 High Similarity NPC276753
0.9577 High Similarity NPC475224
0.9565 High Similarity NPC246947
0.9507 High Similarity NPC95392
0.9507 High Similarity NPC35877
0.9507 High Similarity NPC55715
0.9496 High Similarity NPC113680
0.9496 High Similarity NPC185307
0.9496 High Similarity NPC278961
0.9496 High Similarity NPC470950
0.9429 High Similarity NPC471667
0.9429 High Similarity NPC79429
0.9429 High Similarity NPC470235
0.9429 High Similarity NPC129417
0.9429 High Similarity NPC283995
0.9429 High Similarity NPC217635
0.9424 High Similarity NPC476356
0.9362 High Similarity NPC22150
0.9362 High Similarity NPC279298
0.9362 High Similarity NPC43508
0.9362 High Similarity NPC38041
0.9362 High Similarity NPC476301
0.9357 High Similarity NPC46092
0.9353 High Similarity NPC472711
0.9348 High Similarity NPC156376
0.9338 High Similarity NPC187194
0.9338 High Similarity NPC476411
0.9296 High Similarity NPC112861
0.9281 High Similarity NPC106944
0.9231 High Similarity NPC224674
0.9231 High Similarity NPC275284
0.9231 High Similarity NPC15956
0.9231 High Similarity NPC193473
0.9231 High Similarity NPC39657
0.9231 High Similarity NPC31325
0.9231 High Similarity NPC114505
0.9231 High Similarity NPC213074
0.9225 High Similarity NPC18979
0.922 High Similarity NPC477898
0.9214 High Similarity NPC471908
0.9167 High Similarity NPC270751
0.9161 High Similarity NPC93610
0.9161 High Similarity NPC241846
0.9155 High Similarity NPC84181
0.9149 High Similarity NPC302506
0.9137 High Similarity NPC470413
0.9137 High Similarity NPC138738
0.9118 High Similarity NPC9912
0.9103 High Similarity NPC55158
0.9103 High Similarity NPC286235
0.9103 High Similarity NPC51328
0.9097 High Similarity NPC99183
0.9078 High Similarity NPC76871
0.9065 High Similarity NPC52277
0.9065 High Similarity NPC199459
0.9065 High Similarity NPC177035
0.9044 High Similarity NPC472024
0.9044 High Similarity NPC80600
0.9041 High Similarity NPC238140
0.9041 High Similarity NPC229882
0.9041 High Similarity NPC158635
0.9041 High Similarity NPC98624
0.9034 High Similarity NPC130449
0.9034 High Similarity NPC304048
0.9034 High Similarity NPC226153
0.9034 High Similarity NPC248132
0.9021 High Similarity NPC187774
0.9021 High Similarity NPC472713
0.9021 High Similarity NPC473046
0.9021 High Similarity NPC179521
0.9021 High Similarity NPC118385
0.9021 High Similarity NPC472712
0.9014 High Similarity NPC60249
0.9 High Similarity NPC304152
0.8993 High Similarity NPC184938
0.8993 High Similarity NPC101624
0.8993 High Similarity NPC93783
0.8986 High Similarity NPC25821
0.8973 High Similarity NPC44452
0.8971 High Similarity NPC26653
0.8971 High Similarity NPC270849
0.8958 High Similarity NPC272619
0.8958 High Similarity NPC469586
0.8958 High Similarity NPC286245
0.8944 High Similarity NPC108674
0.8936 High Similarity NPC260842
0.8933 High Similarity NPC11411
0.8921 High Similarity NPC35731
0.8919 High Similarity NPC302610
0.8919 High Similarity NPC478268
0.8912 High Similarity NPC472709
0.8912 High Similarity NPC188393
0.8912 High Similarity NPC470934
0.8912 High Similarity NPC472710
0.8897 High Similarity NPC125755
0.8897 High Similarity NPC302378
0.8889 High Similarity NPC25292
0.8889 High Similarity NPC471065
0.8889 High Similarity NPC253015
0.8889 High Similarity NPC473045
0.8881 High Similarity NPC253878
0.8881 High Similarity NPC472714
0.8881 High Similarity NPC5262
0.8881 High Similarity NPC469559
0.8881 High Similarity NPC189115
0.8873 High Similarity NPC226547
0.8859 High Similarity NPC61604
0.8859 High Similarity NPC299706
0.8859 High Similarity NPC245615
0.8859 High Similarity NPC115466
0.8857 High Similarity NPC236522
0.8857 High Similarity NPC470236
0.8851 High Similarity NPC473621
0.8832 High Similarity NPC166040
0.8832 High Similarity NPC248355
0.8828 High Similarity NPC161700
0.8828 High Similarity NPC277867
0.8828 High Similarity NPC475096
0.8824 High Similarity NPC149873
0.8824 High Similarity NPC7191
0.8819 High Similarity NPC473044
0.8816 High Similarity NPC478269
0.8811 High Similarity NPC470372
0.8811 High Similarity NPC469661
0.8811 High Similarity NPC471414
0.8794 High Similarity NPC164857
0.8794 High Similarity NPC77861
0.8794 High Similarity NPC25695
0.8794 High Similarity NPC172818
0.8792 High Similarity NPC474442
0.8786 High Similarity NPC47181
0.8786 High Similarity NPC470881
0.8777 High Similarity NPC104077
0.8777 High Similarity NPC219671
0.8777 High Similarity NPC254275
0.8777 High Similarity NPC471505
0.8777 High Similarity NPC147616
0.8777 High Similarity NPC106739
0.8777 High Similarity NPC259742
0.8776 High Similarity NPC116229
0.8776 High Similarity NPC280945
0.8767 High Similarity NPC476865
0.8767 High Similarity NPC190714
0.8767 High Similarity NPC99515
0.8759 High Similarity NPC76176
0.8759 High Similarity NPC138227
0.8759 High Similarity NPC469313
0.8759 High Similarity NPC168579
0.8759 High Similarity NPC470084
0.875 High Similarity NPC473792
0.875 High Similarity NPC206882
0.875 High Similarity NPC473873
0.875 High Similarity NPC48309
0.8741 High Similarity NPC55793
0.8732 High Similarity NPC185908
0.8732 High Similarity NPC283949
0.8732 High Similarity NPC469981
0.8723 High Similarity NPC135777
0.8723 High Similarity NPC142547
0.8723 High Similarity NPC18576
0.8716 High Similarity NPC471062
0.8716 High Similarity NPC476398
0.8716 High Similarity NPC94871
0.8716 High Similarity NPC473427
0.8716 High Similarity NPC259347
0.8716 High Similarity NPC306890
0.8716 High Similarity NPC476386
0.8716 High Similarity NPC470933
0.8714 High Similarity NPC215833
0.8714 High Similarity NPC69513
0.8714 High Similarity NPC6836
0.8714 High Similarity NPC196937
0.8707 High Similarity NPC175275
0.8707 High Similarity NPC15538
0.8707 High Similarity NPC227902
0.8707 High Similarity NPC473480
0.8705 High Similarity NPC476345
0.8705 High Similarity NPC65942
0.8705 High Similarity NPC248307
0.8701 High Similarity NPC478267
0.8699 High Similarity NPC476868
0.8699 High Similarity NPC100998
0.8699 High Similarity NPC476382
0.8699 High Similarity NPC34927
0.8699 High Similarity NPC476864
0.8699 High Similarity NPC287615
0.8699 High Similarity NPC216819
0.8699 High Similarity NPC252292
0.8699 High Similarity NPC34587
0.8699 High Similarity NPC262182
0.8699 High Similarity NPC476869
0.8699 High Similarity NPC83743
0.8699 High Similarity NPC476866
0.8693 High Similarity NPC173726
0.8693 High Similarity NPC241600
0.869 High Similarity NPC37793
0.8684 High Similarity NPC163635
0.8684 High Similarity NPC228357
0.8681 High Similarity NPC273932

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC471063 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8552 High Similarity NPD6674 Discontinued
0.8288 Intermediate Similarity NPD7266 Discontinued
0.8116 Intermediate Similarity NPD3705 Approved
0.8086 Intermediate Similarity NPD7228 Approved
0.8077 Intermediate Similarity NPD8455 Phase 2
0.8042 Intermediate Similarity NPD3027 Phase 3
0.8 Intermediate Similarity NPD7240 Approved
0.8 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD1613 Approved
0.7898 Intermediate Similarity NPD37 Approved
0.7895 Intermediate Similarity NPD5058 Phase 3
0.7888 Intermediate Similarity NPD7199 Phase 2
0.7879 Intermediate Similarity NPD7472 Approved
0.7879 Intermediate Similarity NPD7074 Phase 3
0.7862 Intermediate Similarity NPD4965 Approved
0.7862 Intermediate Similarity NPD4967 Phase 2
0.7862 Intermediate Similarity NPD4966 Approved
0.7857 Intermediate Similarity NPD1091 Approved
0.7844 Intermediate Similarity NPD7808 Phase 3
0.7818 Intermediate Similarity NPD7054 Approved
0.7778 Intermediate Similarity NPD2861 Phase 2
0.777 Intermediate Similarity NPD1357 Approved
0.7764 Intermediate Similarity NPD6234 Discontinued
0.7756 Intermediate Similarity NPD1653 Approved
0.7724 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7721 Intermediate Similarity NPD5283 Phase 1
0.7683 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7679 Intermediate Similarity NPD7251 Discontinued
0.7679 Intermediate Similarity NPD7685 Pre-registration
0.7655 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7651 Intermediate Similarity NPD3818 Discontinued
0.7647 Intermediate Similarity NPD7843 Approved
0.7619 Intermediate Similarity NPD6797 Phase 2
0.7613 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7609 Intermediate Similarity NPD7157 Approved
0.7603 Intermediate Similarity NPD4908 Phase 1
0.7582 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.755 Intermediate Similarity NPD5588 Approved
0.75 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7483 Intermediate Similarity NPD4536 Approved
0.7483 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7483 Intermediate Similarity NPD7097 Phase 1
0.7483 Intermediate Similarity NPD4538 Approved
0.7467 Intermediate Similarity NPD5735 Approved
0.7465 Intermediate Similarity NPD5125 Phase 3
0.7465 Intermediate Similarity NPD5126 Approved
0.7455 Intermediate Similarity NPD8127 Discontinued
0.7451 Intermediate Similarity NPD1375 Discontinued
0.7448 Intermediate Similarity NPD8651 Approved
0.74 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.74 Intermediate Similarity NPD3620 Phase 2
0.7396 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7384 Intermediate Similarity NPD8313 Approved
0.7384 Intermediate Similarity NPD8312 Approved
0.7378 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7378 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7361 Intermediate Similarity NPD1610 Phase 2
0.7353 Intermediate Similarity NPD2684 Approved
0.7351 Intermediate Similarity NPD6355 Discontinued
0.7338 Intermediate Similarity NPD5762 Approved
0.7338 Intermediate Similarity NPD5763 Approved
0.7326 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7321 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7321 Intermediate Similarity NPD6166 Phase 2
0.7321 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.732 Intermediate Similarity NPD5960 Phase 3
0.732 Intermediate Similarity NPD6028 Clinical (unspecified phase)
0.732 Intermediate Similarity NPD4108 Discontinued
0.732 Intermediate Similarity NPD6029 Clinical (unspecified phase)
0.7315 Intermediate Similarity NPD7095 Approved
0.7308 Intermediate Similarity NPD6331 Phase 2
0.7308 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7308 Intermediate Similarity NPD4110 Phase 3
0.7301 Intermediate Similarity NPD2977 Approved
0.7301 Intermediate Similarity NPD2978 Approved
0.7289 Intermediate Similarity NPD5494 Approved
0.7285 Intermediate Similarity NPD4060 Phase 1
0.7268 Intermediate Similarity NPD7680 Approved
0.7267 Intermediate Similarity NPD6559 Discontinued
0.726 Intermediate Similarity NPD2983 Phase 2
0.726 Intermediate Similarity NPD2982 Phase 2
0.7256 Intermediate Similarity NPD6374 Clinical (unspecified phase)
0.725 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7244 Intermediate Similarity NPD4237 Approved
0.7244 Intermediate Similarity NPD4236 Phase 3
0.7239 Intermediate Similarity NPD1934 Approved
0.7238 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7215 Intermediate Similarity NPD6783 Clinical (unspecified phase)
0.7212 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7202 Intermediate Similarity NPD3051 Approved
0.7194 Intermediate Similarity NPD228 Approved
0.7192 Intermediate Similarity NPD2981 Phase 2
0.719 Intermediate Similarity NPD6653 Approved
0.7181 Intermediate Similarity NPD3018 Phase 2
0.7171 Intermediate Similarity NPD4140 Approved
0.716 Intermediate Similarity NPD6055 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD2969 Approved
0.716 Intermediate Similarity NPD2970 Approved
0.7152 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD5327 Phase 3
0.7134 Intermediate Similarity NPD7945 Clinical (unspecified phase)
0.7125 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7117 Intermediate Similarity NPD7028 Phase 2
0.711 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD6233 Phase 2
0.7103 Intermediate Similarity NPD6516 Phase 2
0.7103 Intermediate Similarity NPD5846 Approved
0.7101 Intermediate Similarity NPD3787 Discontinued
0.7093 Intermediate Similarity NPD5844 Phase 1
0.7091 Intermediate Similarity NPD5772 Approved
0.7091 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD5773 Approved
0.7089 Intermediate Similarity NPD4628 Phase 3
0.7081 Intermediate Similarity NPD52 Approved
0.7081 Intermediate Similarity NPD7527 Clinical (unspecified phase)
0.7081 Intermediate Similarity NPD7526 Approved
0.7059 Intermediate Similarity NPD1558 Phase 1
0.7051 Intermediate Similarity NPD2161 Phase 2
0.705 Intermediate Similarity NPD3021 Approved
0.705 Intermediate Similarity NPD3022 Approved
0.7048 Intermediate Similarity NPD3817 Phase 2
0.7044 Intermediate Similarity NPD2677 Approved
0.7039 Intermediate Similarity NPD6798 Discontinued
0.703 Intermediate Similarity NPD3382 Approved
0.703 Intermediate Similarity NPD3384 Approved
0.703 Intermediate Similarity NPD3383 Approved
0.7029 Intermediate Similarity NPD290 Approved
0.7027 Intermediate Similarity NPD3685 Discontinued
0.7027 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7027 Intermediate Similarity NPD4749 Approved
0.7025 Intermediate Similarity NPD4162 Approved
0.7025 Intermediate Similarity NPD5177 Phase 3
0.7022 Intermediate Similarity NPD6843 Phase 3
0.7022 Intermediate Similarity NPD6842 Approved
0.7022 Intermediate Similarity NPD6841 Approved
0.7022 Intermediate Similarity NPD7906 Approved
0.702 Intermediate Similarity NPD5752 Clinical (unspecified phase)
0.7018 Intermediate Similarity NPD2489 Approved
0.7018 Intermediate Similarity NPD27 Approved
0.7 Intermediate Similarity NPD6071 Discontinued
0.6993 Remote Similarity NPD1726 Clinical (unspecified phase)
0.6993 Remote Similarity NPD6671 Approved
0.6989 Remote Similarity NPD7312 Approved
0.6989 Remote Similarity NPD7311 Approved
0.6989 Remote Similarity NPD7310 Approved
0.6989 Remote Similarity NPD7313 Approved
0.6988 Remote Similarity NPD5563 Clinical (unspecified phase)
0.6988 Remote Similarity NPD6818 Clinical (unspecified phase)
0.6981 Remote Similarity NPD6658 Clinical (unspecified phase)
0.6981 Remote Similarity NPD4535 Phase 3
0.6975 Remote Similarity NPD5261 Clinical (unspecified phase)
0.6974 Remote Similarity NPD4625 Phase 3
0.6968 Remote Similarity NPD6353 Approved
0.6966 Remote Similarity NPD1548 Phase 1
0.6959 Remote Similarity NPD1608 Approved
0.6949 Remote Similarity NPD7309 Approved
0.6949 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6948 Remote Similarity NPD5837 Clinical (unspecified phase)
0.6946 Remote Similarity NPD2560 Approved
0.6946 Remote Similarity NPD2563 Approved
0.6937 Remote Similarity NPD5307 Clinical (unspecified phase)
0.6937 Remote Similarity NPD5084 Clinical (unspecified phase)
0.6933 Remote Similarity NPD2122 Discontinued
0.6928 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6923 Remote Similarity NPD7119 Phase 2
0.6918 Remote Similarity NPD1652 Phase 2
0.6918 Remote Similarity NPD3060 Approved
0.6914 Remote Similarity NPD4123 Phase 3
0.6912 Remote Similarity NPD291 Approved
0.6905 Remote Similarity NPD3882 Suspended
0.6903 Remote Similarity NPD5124 Phase 1
0.6903 Remote Similarity NPD3657 Discovery
0.6903 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6901 Remote Similarity NPD5535 Approved
0.6899 Remote Similarity NPD2029 Clinical (unspecified phase)
0.6897 Remote Similarity NPD5536 Phase 2
0.689 Remote Similarity NPD3686 Approved
0.689 Remote Similarity NPD3687 Approved
0.689 Remote Similarity NPD4210 Discontinued
0.6889 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6887 Remote Similarity NPD6584 Phase 3
0.6886 Remote Similarity NPD7819 Suspended
0.6886 Remote Similarity NPD2801 Approved
0.6886 Remote Similarity NPD1465 Phase 2
0.6879 Remote Similarity NPD7033 Discontinued
0.6875 Remote Similarity NPD7466 Approved
0.6872 Remote Similarity NPD4663 Approved
0.6871 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6867 Remote Similarity NPD4772 Phase 2
0.6867 Remote Similarity NPD4773 Phase 2
0.6864 Remote Similarity NPD7833 Phase 2
0.6864 Remote Similarity NPD7831 Phase 2
0.6864 Remote Similarity NPD7832 Clinical (unspecified phase)
0.6864 Remote Similarity NPD5604 Discontinued
0.6855 Remote Similarity NPD2424 Discontinued
0.6852 Remote Similarity NPD1774 Approved
0.6848 Remote Similarity NPD4005 Discontinued
0.6846 Remote Similarity NPD2231 Phase 2
0.6846 Remote Similarity NPD2235 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data